Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 5 analysts offering 12 month price targets for InnoCare Pharma Ltd have a median target of 8.79, with a high estimate of 9.80 and a low estimate of 5.90. The median estimate represents a 17.42% increase from the last price of 7.49.
High | 30.8% | 9.80 |
Med | 17.4% | 8.79 |
Low | -21.3% | 5.90 |
Earnings history & estimates in CNY
Average growth rate | -324.03% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +25,448.91% |
More ▼